Advancing clinical research globally: Cervical cancer research network from Mexico

Gynecol Oncol Rep. 2018 Jun 12;25:90-93. doi: 10.1016/j.gore.2018.06.007. eCollection 2018 Aug.

Abstract

Cervical cancer is the fourth most common cancer in women with 85% of the mortality burden occurring in less-developed regions of the world. The Cervix Cancer Research Network (CCRN) was founded by the Gynecologic Cancer InterGroup (GCIG) with a mission to improve outcomes in cervix cancer by increasing access to high-quality clinical trials worldwide, with particular attention to less-developed, underrepresented sites. The CCRN held its second international educational symposium in Mexico City with ninety participants from fifteen Latin America countries in January 2017. The purpose of this symposium was to advance knowledge in cervix cancer therapy, promote recruitment to CCRN clinical trials, and to identify relevant future CCRN clinical trial concepts that could improve global care standards for women with cervical cancer.

Keywords: CCRN; Cervical cancer; Cervix cancer; Hypofractionation; Radiotherapy.

Publication types

  • Review